Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment
about
Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentEpigenetics in Alzheimer's Disease: Perspective of DNA Methylation.An emerging role for epigenetic factors in relation to executive function.
P2860
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@ast
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@en
type
label
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@ast
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@en
prefLabel
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@ast
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@en
P2093
P2860
P921
P1433
P1476
Development of Biomarkers Base ...... esic Mild Cognitive Impairment
@en
P2093
Hisashi Yamada
Kazuhiko Nakayama
Kazuhiro Kondo
Koji Kasanuki
Nobuto Shibata
Nobuyuki Kobayashi
Shunichiro Shinagawa
Tohru Ohnuma
Tomoyuki Nagata
P2860
P304
P356
10.1371/JOURNAL.PONE.0146449
P407
P577
2016-01-07T00:00:00Z